These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9413804)

  • 21. Absence of suppressive effect of somatostatin on prolactin levels in patients with hyperprolactinemia.
    Bronstein MD; Knoepfelmacher M; Liberman B; Marino R; Germek OA; Schally AV
    Horm Metab Res; 1987 Jun; 19(6):271-4. PubMed ID: 2887502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Headache, hyperprolactinemia, and prolactinomas.
    Strebel PM; Zacur HA; Gold EB
    Obstet Gynecol; 1986 Aug; 68(2):195-9. PubMed ID: 3737035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced dopaminergic inhibition of thyrotropin release in hyperprolactinemic ovulatory women.
    Larrea F; Escorza A; Valencia X; Méndez I; Schiavon R; Forsbach G
    Rev Invest Clin; 1991; 43(4):293-8. PubMed ID: 1798861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulsatile prolactin secretion in hyperprolactinemia due to presumed pituitary stalk interruption.
    Samuels MH; Henry P; Kleinschmidt-Demasters B; Lillehei K; Ridgway EC
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1289-93. PubMed ID: 1955511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma aldosterone response to metoclopramide is unmodified by hyperprolactinemia.
    Serri O
    Horm Res; 1987; 27(1):36-41. PubMed ID: 3623428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catecholamines and pituitary function. VI. Effect of different dopamine doses on TRH-induced prolactin release in women with pathological hyperprolactinemia.
    Nicoletti I; Ambrosi F; Pagliacci MC; Pelicci G; Giammartino C; Maggio D; Fedeli L; Filipponi P
    Horm Metab Res; 1987 Mar; 19(3):125-9. PubMed ID: 3106177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Influence of hyperprolactinemia and tumoral size in the postoperative pituitary function in clinically nonfunctioning pituitary macroadenomas].
    Fonseca AL; Chimelli L; Santos MJ; Santos AA; Violante AH
    Arq Neuropsiquiatr; 2002 Sep; 60(3-A):590-602. PubMed ID: 12244397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macroprolactinemia in patients with prolactinomas: prevalence and clinical significance.
    Elenkova A; Genov N; Abadzhieva Z; Kirilov G; Vasilev V; Kalinov K; Zacharieva S
    Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):201-5. PubMed ID: 23595795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolactin lowering effect of amphetamine in normoprolactinemic subjects and in physiological and pathological hyperprolactinemia.
    DeLeo V; Cella SG; Camanni F; Genazzani AR; Müller EE
    Horm Metab Res; 1983 Sep; 15(9):439-43. PubMed ID: 6642414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum prolactin concentration at presentation of non-functioning pituitary macroadenomas.
    Behan LA; O'Sullivan EP; Glynn N; Woods C; Crowley RK; Tun TK; Smith D; Thompson CJ; Agha A
    J Endocrinol Invest; 2013; 36(7):508-14. PubMed ID: 23385474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normal lactotroph sensitivity to graded low-dose dopamine infusions in pathological hyperprolactinemia.
    Ho KY; Smythe GA; Lazarus L
    Neuroendocrinology; 1986; 43(2):175-81. PubMed ID: 3724984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms.
    Schuff KG; Hentges ST; Kelly MA; Binart N; Kelly PA; Iuvone PM; Asa SL; Low MJ
    J Clin Invest; 2002 Oct; 110(7):973-81. PubMed ID: 12370275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicentric experience on the acute effect of nomifensine in hyperprolactinemic women.
    Minuto F; Barbarino A; Baviera G; Mazzocchi G; De Marinis L; Leonardi R; Bernasconi D; Menini E; Maira G; Anile C
    J Endocrinol Invest; 1984 Apr; 7(2):137-40. PubMed ID: 6725869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium and prolactin secretion in humans: effects of the channel blocker, verapamil, in the spontaneous and drug-induced hyperprolactinemia.
    Knoepfelmacher M; Villares SM; Nicolau W; Germek OO; Lerário AC; Wajchenberg BL; Liberman B
    Horm Metab Res; 1994 Oct; 26(10):481-5. PubMed ID: 7851873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in the opioid control of luteinizing hormone secretion between pathological and iatrogenic hyperprolactinemic states.
    Petraglia F; De Leo V; Nappi C; Facchinetti F; Montemagno U; Brambilla F; Genazzani AR
    J Clin Endocrinol Metab; 1987 Mar; 64(3):508-12. PubMed ID: 2880862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is idiopathic hyperprolactinemia a transitional stage toward prolactinoma?
    Pereira MC; Sobrinho LG; Afonso AM; Ferreira JM; Santos MA; Sousa MF
    Obstet Gynecol; 1987 Sep; 70(3 Pt 1):305-8. PubMed ID: 3114691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cabergoline: long-acting oral treatment of hyperprolactinemic disorders.
    Ferrari C; Mattei A; Melis GB; Paracchi A; Muratori M; Faglia G; Sghedoni D; Crosignani PG
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1201-6. PubMed ID: 2656736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender-related differences in prolactin secretion in pituitary prolactinomas.
    Nishioka H; Haraoka J; Akada K; Azuma S
    Neuroradiology; 2002 May; 44(5):407-10. PubMed ID: 12012125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathologic study of 123 cases of prolactin-secreting pituitary adenomas with special reference to multihormone production and clonality of the adenomas.
    Ma W; Ikeda H; Yoshimoto T
    Cancer; 2002 Jul; 95(2):258-66. PubMed ID: 12124824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The GABAergic control of prolactin release is not affected by insulin-dependent diabetes mellitus: evidence from studies with sodium valproate.
    Coiro V; Davoli C; Volpi R; Sorini E; Voltini E; Rossi G; Delsignore R; Gnudi A; Chiodera P
    Acta Diabetol Lat; 1986; 23(1):51-5. PubMed ID: 3012924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.